Terapet raises EUR 772,000

A CERN spin-off based in Geneva, Terapet develops PET-type technologies to verify in vivo the dose delivered in proton therapy. Under the Eurostars TheraVivo project, it has received EUR 772,000 in funding.

Announced on
Round
Grant
Amount
EUR 772,000
Location
Geneva
Sector
Health & medtech

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic